View in EDS

Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma.

Saved in:
Bibliographic Details
Title: Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma.
Authors: Koch MS; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA., Zdioruk M; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA., Nowicki MO; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA., Griffith AM; Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Aguilar-Cordova E; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA., Aguilar LK; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA., Guzik BW; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA., Barone F; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA., Tak PP; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA., Schregel K; Department of Neuroradiology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany., Hoetker MS; Department of Molecular Biology, Massachusetts General Hospital, 185 Cambridge St, Boston, MA 02114, USA., Lederer JA; Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA., Chiocca EA; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institut for Clinical Brain Research, Eberhard Karls University Tübingen, Hoppe-Seyler-Straße 6, 72076 Tübingen, Germany., Lawler SE; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.
Source: Molecular therapy oncolytics [Mol Ther Oncolytics] 2022 Jul 31; Vol. 26, pp. 275-288. Date of Electronic Publication: 2022 Jul 31 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36032633
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koch+MS%22">Koch MS</searchLink>; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Zdioruk+M%22">Zdioruk M</searchLink>; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Nowicki+MO%22">Nowicki MO</searchLink>; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Griffith+AM%22">Griffith AM</searchLink>; Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Aguilar-Cordova+E%22">Aguilar-Cordova E</searchLink>; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA.<br /><searchLink fieldCode="AU" term="%22Aguilar+LK%22">Aguilar LK</searchLink>; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA.<br /><searchLink fieldCode="AU" term="%22Guzik+BW%22">Guzik BW</searchLink>; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA.<br /><searchLink fieldCode="AU" term="%22Barone+F%22">Barone F</searchLink>; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA.<br /><searchLink fieldCode="AU" term="%22Tak+PP%22">Tak PP</searchLink>; Candel Therapeutics, 117 Kendrick St, Suite 450, Needham, MA 02494, USA.<br /><searchLink fieldCode="AU" term="%22Schregel+K%22">Schregel K</searchLink>; Department of Neuroradiology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoetker+MS%22">Hoetker MS</searchLink>; Department of Molecular Biology, Massachusetts General Hospital, 185 Cambridge St, Boston, MA 02114, USA.<br /><searchLink fieldCode="AU" term="%22Lederer+JA%22">Lederer JA</searchLink>; Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Chiocca+EA%22">Chiocca EA</searchLink>; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.<br /><searchLink fieldCode="AU" term="%22Tabatabai+G%22">Tabatabai G</searchLink>; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institut for Clinical Brain Research, Eberhard Karls University Tübingen, Hoppe-Seyler-Straße 6, 72076 Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lawler+SE%22">Lawler SE</searchLink>; Harvey Cushing Neurooncology Research Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101666776%22">Molecular therapy oncolytics</searchLink> [Mol Ther Oncolytics] 2022 Jul 31; Vol. 26, pp. 275-288. <i>Date of Electronic Publication: </i>2022 Jul 31 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101666776 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2372-7705 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223727705%22">23727705 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncolytics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36032633
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omto.2022.07.009
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 275
    Titles:
      – TitleFull: Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koch MS
      – PersonEntity:
          Name:
            NameFull: Zdioruk M
      – PersonEntity:
          Name:
            NameFull: Nowicki MO
      – PersonEntity:
          Name:
            NameFull: Griffith AM
      – PersonEntity:
          Name:
            NameFull: Aguilar-Cordova E
      – PersonEntity:
          Name:
            NameFull: Aguilar LK
      – PersonEntity:
          Name:
            NameFull: Guzik BW
      – PersonEntity:
          Name:
            NameFull: Barone F
      – PersonEntity:
          Name:
            NameFull: Tak PP
      – PersonEntity:
          Name:
            NameFull: Schregel K
      – PersonEntity:
          Name:
            NameFull: Hoetker MS
      – PersonEntity:
          Name:
            NameFull: Lederer JA
      – PersonEntity:
          Name:
            NameFull: Chiocca EA
      – PersonEntity:
          Name:
            NameFull: Tabatabai G
      – PersonEntity:
          Name:
            NameFull: Lawler SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 07
              Text: 2022 Jul 31
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2372-7705
          Numbering:
            – Type: volume
              Value: 26
          Titles:
            – TitleFull: Molecular therapy oncolytics
              Type: main
ResultId 1